Pharmaceutical giant AstraZeneca has announced it will establish a major strategic hub in Lisbon, reinforcing Portugal’s growing role in the global life sciences sector. The British-Swedish multinational plans to create a multidisciplinary centre in the capital that will focus on research and development, operational support, and digital innovation. The new site will be located in […]
Portugal’s biotechnology and pharmaceutical sectors have become the backbone of the country’s health-related exports, accounting for more than 80 percent of the total value of goods exported within the health industry, according to figures published by AICEP, Portugal’s national agency for trade and investment. This export dominance signals a maturing life sciences ecosystem and a
The Portuguese Bioindustry Association, P-BIO, has unveiled its strategic roadmap for the country’s life sciences sector, laying out a bold and long-term vision under the title BIO-HEALTH 2030. The document outlines how Portugal can position itself as a major European hub for innovation in biotechnology, health technologies, and advanced therapies over the next five years.The
BIAL, Portugal’s century-old biopharmaceutical champion, has become a founding member of the Orphan Therapeutics Accelerator (OTXL), a nonprofit biotech initiative launched in June 2024 to revive and advance treatments for ultra rare diseases.In a statement released in April 2025, BIAL confirmed its commitment to help identify, develop, and commercialize two to three discontinued therapeutic programs
